Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study

Santos, Thainá Rodrigues Melo; Melo, Juliana Valéria de; Leite, Nathalie C.; Salles, Gilles; Cardoso, Claudia R.L.

doi:10.1016/j.jdiacomp.2018.05.010

Cited by 37 publications

(42 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hayes et al's study found significant kappa values (denoted by κ) obtained from incomplete SCI patients for the association between VPT and light touch values for the right L4 (κ = 0.25) and left L4 (κ = 0.29) dermatomes and also a significant correlation between VPT and pinprick for the right L4 dermatome (κ = 0.33) (6). In addition, Santos et al investigated the relationship between VPT and neuropathic signs of patients with type two diabetes, and found a clear trend toward progressively greater VPT in patients with mild and moderate/severe signs in contrast to patients with absent neuropathic signs (12).…”

Section: Consistencymentioning

confidence: 99%

“…Recently vibration perception threshold (VPT) by quantitative sensory testing (QST) has been proposed as a method to assess the somatosensory pathways in clinical trials (7,8). Multiple studies showed that VPT was a sensitive measure of peripheral neuropathy (9)(10)(11)(12)(13)(14)(15)(16)(17). The QST method for measuring VPTs has shown higher reliability than the tuning fork testing (7).…”

Section: Introductionmentioning

confidence: 99%

“…As one of QST computerized devices, the Vibration Sensory Analyzer VSA-3000 (Medoc) was designed to assess vibration. VPT assessed by VSA-3000 has been most commonly used in detecting peripheral neuropathy (9,(12)(13)(14)(19)(20)(21)(22)(23). Recent studies showed that QST using VSA-3000 (or other devices) was also a useful adjunct measurement with good reliability of detection thresholds in central nervous system diseases (6,(24)(25)(26)(27)(28).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

VSA-3000: A Quantitative Vibration Sensation Testing Device for Patients With Central Nervous System Injury

2020

View full text Add to dashboard Cite

Objective: To investigate the effect of using Vibration Sensory Analyzer-3000 (VSA-3000) in patients with impaired vibration sensation caused by central nervous system injury. Design: Prospective observational study. Setting: A university hospital for the research and clinical practice of rehabilitation. Subjects: Sixty patients (30 stroke and 30 spinal cord injury) were recruited, aged between 20 and 71 years old, under stable medication. Interventions: Not applicable. Main Measure: VSA-3000 threshold test, tuning fork test and somatosensory evoked potential (SSEP) measurement. Results: Test-retest reliability was determined based on data collected from 60 subjects, and the intraclass correlation coefficient (ICC) for vibration perception thresholds (VPTs) was in the "substantial" range. The kappa value between VSA-3000 and SSEP was 0.877, which was higher than that of tuning fork (κ = 0.732). VSA-3000 had good diagnostic accuracy with a sensitivity of 94.8%, specificity of 92.9%, and positive-predictive value of 93.8% and negative-predictive value of 94.0%, each value was higher than that of tuning fork. The area under the receiver operating characteristic curve (AUC) of VSA-3000 was 0.95 (95% CI: 0.91 to 0.98) and that of tuning fork was 0.89 (95% CI: 0.85 to 0.95), and there was a significant difference between the two values (P = 0.0216). The types of injury and age were the independent correlates of the VPTs. Conclusion: The present study provides preliminary evidence that VSA-3000 is a non-invasive and convenient quantitative testing instrument with good diagnostic accuracy, and it may be useful as a screening tool for assessing impaired vibration sensation caused by central nerve injury.

show abstract

Section: Consistencymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

VSA-3000: A Quantitative Vibration Sensation Testing Device for Patients With Central Nervous System Injury

2020

View full text Add to dashboard Cite

show abstract

“…Definitely, future geographical cohort study need to as proving such a complement evidence association, and taking into account the race of this association could change the medical criteria of NPD [44][45][46][47].…”

Section: Discussionmentioning

confidence: 99%

Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: Systemic review, meta-analysis and meta-regression analysis of observational studies

Naqvi

imani

Hosseinifard

et al. 2019

Preprint

View full text Add to dashboard Cite

Background:Compositional abnormalities in lipoproteins and cardiovascular risk factors play an important role in the progression of diabetic peripheral neuropathy (DPN). This systematic review aimed to estimate the predicting value of low-density lipoprotein (LDL) and systolic blood pressure (SBP) level in type-2 diabetes mellitus (T2DM) patients with and without peripheral neuropathy. We also tried to determine whether LDL and SBP are associated with an increased collision risk of DPN. Materials and Methods:A systematic search was conducted for eligible publications which explored the LDL and SBP level in T2DM patients with and without peripheral neuropathy. The quality of the included studies was assessed by the QUADAS-2 tool. The standardized mean difference (SMD) with 95% CI of LDL and SBP level were pooled to assess the correlation between LDL and SBP level with DPN. We performed random effects meta-regression analyses to investigate factors associated with an increased collision risk of DPN. Results:There was a significant association between LDL and SBP with poor prognosis of DPN in those included studies (I2= 88.1% and I2= 84.9%, respectively, Both P < 0.001). European T2DM patients have higher serum level of LDL in compare with the European DPN patients (SMD = 0.16, 95 % CI: -0.06 - 0.38; P <0.001). SBP level was associated with a 2.6-fold decrease in non-DPN patients of T2DM (SMD = -2.63, 95% CI: -4.00 - -1.27, P <0.001). Old age European T2DM patients have significantly high risk for diabetes drivers. Furthermore, the results of the case-control study design model are more precise to show the accuracy of SBP in Asian T2DM patients. Conclusion:Our finding supports the LDL and SBP status could be associated with increased risk of peripheral neuropathy in T2DM patients.

show abstract

“…8,9 This factor is the gold standard for the diagnosis of diabetes, and measuring hemoglobin A1C is an approved method for diagnosing diabetes in most people. 10 The hemoglobin A1C test is more convenient for patients, because it does not require fasting, 11 and a result greater than or equal to 6.5% indicates diabetes. 12,13 People with hemoglobin A1C test results in the range of 5.7%-6.4% are at high risk for diabetes and should receive effective interventions such as weight reduction and physical exercise.…”

Section: Introductionmentioning

confidence: 99%

The Impact of Biofeedback on Diabetic Patients’ Glycemia

2018

View full text Add to dashboard Cite

Background: Complementary medicine claims that biofeedback affects the reduction of blood glycemia. Objective: The current study aimed to determine the effects of biofeedback on decreasing blood glucose levels and tension and increasing the quality of life in diabetic patients. Methods: The current retrospective evidence-based study used pretest-posttest accidental sampling to select a group of 30 diabetic patients admitted to Glenview Clinic in the Aghdasiyeh region, Tehran, Iran, as the sample. Participants were divided into two 15-membered groups, the experiment and the control groups, matched by age and gender. Data gathering tools included the Quality of Life questionnaire in diabetic patients by Thomas et al, the Perceived Tension Index by Cohen et al, a glucometer, and the fasting blood glucose test. Data was analyzed using analysis of covariance (ANCOVA). Results: The results showed that biofeedback training was effective in decreasing blood glucose levels in diabetic patients. Conclusion: Biofeedback can reduce tension and improve the quality of life of diabetic patients; thus, it could be used as a complementary service in healthcare centers.

show abstract

Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study

Cited by 37 publications

References 38 publications

VSA-3000: A Quantitative Vibration Sensation Testing Device for Patients With Central Nervous System Injury

VSA-3000: A Quantitative Vibration Sensation Testing Device for Patients With Central Nervous System Injury

Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: Systemic review, meta-analysis and meta-regression analysis of observational studies

The Impact of Biofeedback on Diabetic Patients’ Glycemia

Contact Info

Product

Resources

About